Columnist Juliet Taylor chats with Roon CEO and co-founder Vikram Bhaskaran about this new ALS app designed for patients and ...
Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore ...
A $500,000 MDA research grant to a Mass General investigator will support the HEALEY ALS platform trial that's testing ...
A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...
Clene will have an in-person meeting with the FDA before the end of November to discuss a potential CNM-Au8 accelerated ...
A short course of treatment with RNS60, as an add-on to riluzole, extended the survival of ALS patients by about six months, ...
Amprion has been awarded a $100,000 research grant to support studies on the causes of sporadic amyotrophic lateral sclerosis (ALS) that could help diagnose and develop potential therapies for the ...
When life is difficult, small things make a big difference, columnist Kristin Neva writes. She and her husband, Todd, are still learning.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback